News
Beckman Coulter Life Sciences, laboratory automation and innovation specialists, has launched its new IR820 and IR870 infrared dye antibody conjugates, created to provide research ...
To address the challenge, Sino Biological has developed anti-whitlow 218 linker rabbit monoclonal antibodies, which specifically binds to the whitlow 218 linker sequence (GSTSGSGKPGSGEGSTKG). The ...
A biohybrid system, capable of mimicking the biological interface between bones and muscles, has been developed by ...
Körber is broadening its network in the Human Machine Interfaces (HMI) sector by partnering with Pepperl+Fuchs, a provider of ...
An international team of scientists have shared how rogue rings of DNA that float outside of our chromosomes, known as ...
Researchers have identified specific nerve pathways responsible for relaying pain signals from the bowel to the brain, enabling researcher into new treatments for irritable bowel syndrome (IBS) and ...
An international team of scientists have shared how rogue rings of DNA that float outside of our chromosomes, known as ...
GNQ Insilico (GNQ), a TechBio firm leveraging exponential technologies for precision medicine, launched its deep tech Drug Assessment Platform (DAP). This system combines artificial intelligence with ...
The research team is a multidisciplinary partnership that includes academic AI researchers from Old Dominion University, AD scientists from the University of Pennsylvania and Sanford Burnham Prebys, ...
Lab automation systems are customisable and this modularity is a key selling point ...
Based in Cambridge UKBiopharmaceutical company Insmed Incorporated has opened a new research and development (R&D) facility in Cambridge, UK. The new site will focus on synthetic rescue for serious ...
Thereby expanding drug substance capabilitiesEuropean CDMO and specialist in high-quality active pharmaceutical ingredients (APIs), Ofichem, has acquired the Meribel Pharma Solutions’ site in Uppsala, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results